TANDEM DIABETES CARE INC (TNDM)

US8753722037 - Common Stock

35.24  -0.32 (-0.9%)

After market: 35.24 0 (0%)

News Image
11 days ago - InvestorPlace

3 Weight-Loss ETFs to Profit From the Obesity Drug Boom

Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.

News Image
21 days ago - The Motley Fool

1 Beaten-Down Stock That Could Make You Richer

Don't give up on this healthcare stock too soon.

News Image
a month ago - The Motley Fool

Why Tandem Diabetes Care Stock Was Zooming Higher Today

One product in particular could juice the company's fundamentals, a pundit believes.

News Image
a month ago - InvestorPlace

Shhh! 7 Small-Cap Stocks That Can Double by 2025

Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.

News Image
a month ago - Parexel International LLC

Parexel Announces CEO Succession Plan

Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024

News Image
2 months ago - Investor's Business Daily

Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher

On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.

News Image
2 months ago - The Motley Fool

Why Tandem Diabetes Care Stock Popped Today

Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.

News Image
3 months ago - InvestorPlace

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates

When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.

News Image
3 months ago - The Motley Fool

2 Beaten-Down Stocks That Are Worth Buying

Don't be too quick to ignore these stocks.

News Image
5 months ago - FinancialNewsMedia

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END

News Image
5 months ago - FinancialNewsMedia.com

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

/PRNewswire/ -- The global diabetes therapy and treatment market is driven primarily by increased diabetes prevalence, sedentary lifestyles, and most other...